Pharmaceutical Industry Information Portal

HomeExpert Articles

Expert Articles

WHO Interim Statement on composition of current and future COVID-19 vaccines

Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19...

GMP-inspections of veterinary manufacturers in the second half of 2021

The review provides information related to the inspection of manufacturers of medicinal products for veterinary use for compliance with the requirements of the Good Manufacturing Practice (GMP).

What veterinary medicines manufacturers ask about?

On September 22-24, the VI All Russia GMP Conference with international participation, organized by the Ministry of Industry and Trade of Russia together with...

Do I still need the vaccine if I have COVID-19?

Even if you've had COVID infection, that you should go ahead and take the vaccination when it's available to you.

Top biopharma companies could be affected by Brazilian drug patent suspension

GlaxoSmithKline will be the most affected, as it represents 26% of the potentially impacted drugs. This is followed by Novartis at 14%, Sanofi at 11%, and both Pfizer and Bayer with 8%.

Contract production of pharmaceutical ingredients by 2028 may reach $ 136 billion

The traditional active pharmaceutical ingredient dominated the market and accounted for the largest revenue share of 40.5% in 2020.
spot_img

Latest News

spot_img